Mirati Therapeutics, Inc. (NASDAQ: MRTX), a late-stage targeted oncology company, today announced it will present initial preclinical data on the Company's synthetic lethal PRMT5 inhibitor during...

Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company developing drugs to treat cancers with the greatest medical need for new treatment options, including KRAS-mutated...

Blueprint Medicines Corporation (NASDAQ: BPMC) today announced plans to present new data for multiple research- and clinical-stage programs across the company's precision oncology and hematology...

Southwest Gas Holdings, Inc. (NYSE: SWX) management will present at the Siebert Williams Shank - West Coast Utilities Virtual Conference on Wednesday, March 17, 2021. John Hester, president and...

Hillrom (NYSE: HRC) today announced that it will present at KeyBanc Capital Markets' Life Sciences & MedTech Investor Forum on Tuesday, March 23, 2021. John Groetelaars, Hillrom's president and...